Showing 1,161 - 1,180 results of 131,908 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((non decrease) OR (mean decrease)) ))', query time: 1.45s Refine Results
  1. 1161

    Image5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.TIF by Thanyaporn Sang-Ngoen (11241888)

    Published 2021
    “…Bacterial counts were analyzed using standard mean difference (SMD) and by a random effects model with the DerSimonian–Laird estimation.…”
  2. 1162

    Table5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.DOCX by Thanyaporn Sang-Ngoen (11241888)

    Published 2021
    “…Bacterial counts were analyzed using standard mean difference (SMD) and by a random effects model with the DerSimonian–Laird estimation.…”
  3. 1163

    Table5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.DOCX by Thanyaporn Sang-Ngoen (11241888)

    Published 2021
    “…Bacterial counts were analyzed using standard mean difference (SMD) and by a random effects model with the DerSimonian–Laird estimation.…”
  4. 1164

    Image5_Orally Administered Probiotics Decrease Aggregatibacter actinomycetemcomitans but Not Other Periodontal Pathogenic Bacteria Counts in the Oral Cavity: A Systematic Review and Meta-Analysis.TIF by Thanyaporn Sang-Ngoen (11241888)

    Published 2021
    “…Bacterial counts were analyzed using standard mean difference (SMD) and by a random effects model with the DerSimonian–Laird estimation.…”
  5. 1165
  6. 1166
  7. 1167

    Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality by Johannes Raffler (793347)

    Published 2015
    “…In contrast, for the <i>SLC5A11</i> locus, we found increased levels of <i>myo</i>-inositol in urine whereas mGWAS in blood reported decreased levels for the same genetic variant. …”
  8. 1168
  9. 1169

    Descriptives of the study sample, N = 451. by Orrin D. Ware (14829115)

    Published 2025
    “…Most of the sample self-identified as female/woman (77.6%) and White (82.7%). A slight mean decrease was identified in scores for the Stigma of Suicide Scale Short Form: Overall and the Stigma of Suicide Scale Short Form: Stigma Subscale from pre-performance to post-performance. …”
  10. 1170
  11. 1171
  12. 1172
  13. 1173

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…Cells receiving combination therapy had a significant decrease in proliferation compared to cells treated with LG only at 24, 48, and 72 hours, and compared to βHB only at 48, 72, and 96 hours, and exhibited a non-significant trend of decreased proliferation compared to LG + HBOT treated cells for the duration of the growth curve. …”
  14. 1174
  15. 1175
  16. 1176

    MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

    Published 2020
    “…An unpaired student’s t-test detect statistical significance, *p<0.05 for 7.5 wt% hydrogels containing 3 mM RGD relative to either (<b>A, C-F</b>) 15wt% hydrogels containing 3 mM RGD or (<b>G, I-L</b>) 7.5wt% hydrogels containing 1 mM RGD.…”
  17. 1177

    FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

    Published 2013
    “…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”
  18. 1178
  19. 1179
  20. 1180

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…<p>Rh4 and RMS13 cells were treated for 24 hours (A) and 48 hours (B) with different concentrations of fenretinide (0.5–1–5 µM, as indicated). …”